Sterling Investment Counsel, LLC Amgen Inc Transaction History

Sterling Investment Counsel, LLC

$280 Million
Q3 2024

A detailed history of Sterling Investment Counsel, LLC transactions in Amgen Inc stock. As of the latest transaction made, Sterling Investment Counsel, LLC holds 2,109 shares of AMGN stock, worth $621,163. This represents 0.24% of its overall portfolio holdings.

Number of Shares

2,109

Previous 2,096 0.62%

Holding current value

$621,163

Previous $654,000 3.82%

% of portfolio

0.24%

Previous 0.26%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 22, 2024	BUY	$309.38 - $337.38 $4,021 - $4,385	13 Added 0.62%	2,109 $679,000
Q2 2024 Jul 25, 2024	BUY	$262.75 - $319.31 $117,712 - $143,050	448 Added 27.18%	2,096 $654,000
Q1 2024 Apr 26, 2024	SELL	$268.87 - $324.56 $87,920 - $106,131	-327 Reduced 16.56%	1,648 $468,000
Q4 2023 Jan 12, 2024	BUY	$255.7 - $288.46 $73,641 - $83,076	288 Added 17.07%	1,975 $568,000
Q3 2023 Oct 19, 2023	SELL	$218.65 - $271.46 $19,459 - $24,159	-89 Reduced 5.01%	1,687 $453,000
Q2 2023 Jul 17, 2023	SELL	$214.27 - $253.37 $52,710 - $62,329	-246 Reduced 12.17%	1,776 $394,000
Q1 2023 Apr 18, 2023	SELL	$225.79 - $275.2 $90,316 - $110,080	-400 Reduced 16.52%	2,022 $488,000
Q4 2022 Jan 20, 2023	BUY	$229.03 - $291.01 $15,574 - $19,788	68 Added 2.89%	2,422 $0
Q3 2022 Oct 21, 2022	SELL	$224.46 - $253.15 $31,873 - $35,947	-142 Reduced 5.69%	2,354 $531,000
Q2 2022 Oct 20, 2022	BUY	$230.71 - $256.74 $14,765 - $16,431	64 Added 2.63%	2,496 $607,000
Q2 2022 Jul 18, 2022	SELL	$230.71 - $256.74 $25,839 - $28,754	-112 Reduced 4.4%	2,432 $592,000
Q1 2022 May 10, 2022	BUY	$219.27 - $242.57 $268,605 - $297,148	1,225 Added 92.87%	2,544 $615,000
Q4 2021 Apr 29, 2022	BUY	$198.88 - $227.6 $262,322 - $300,204	1,319 New	1,319 $297,000

Others Institutions Holding AMGN

# of Institutions

3,122

Shares Held

410M

Call Options Held

7.56M

Put Options Held

7.2M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $158B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Sterling Investment Counsel, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Sterling Investment Counsel, LLC with notifications on news.

Account

Sterling Investment Counsel, LLC Amgen Inc Transaction History